- OVA1™ is the first and only blood test cleared to help a physician evaluate the likelihood that a woman's ovarian mass is malignant or benign in conjunction with
the physician's evaluation prior to a planned surgery.
- Developed by Vermillion, Inc., OVA1™ is now available nationally to women and their physicians through Quest Diagnostics.
|
|
 |
